The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Socioeconomic disparities in supportive therapy use and tolerance of aromatase inhibitors in patients with early-stage, hormone-positive breast cancer.
 
Melanie Wain Kier
No Relationships to Disclose
 
Zhiqiang Li
Employment - Sema4
Stock and Other Ownership Interests - Sema4
 
Nicole Casasanta
No Relationships to Disclose
 
Rima Patel
No Relationships to Disclose
 
Parul Agarwal
No Relationships to Disclose
 
Brittney Shulman Zimmerman
No Relationships to Disclose
 
Yunchen Yang
Employment - Sema4
Stock and Other Ownership Interests - Sema4
 
Marc Y Fink
Employment - Sema4
Stock and Other Ownership Interests - Sema4
 
Xiang Zhou
Employment - SEMA4
 
Scott Newman
Employment - Sema4
Stock and Other Ownership Interests - Sema4
 
Rong Chen
Employment - Sema4
Stock and Other Ownership Interests - Personalis; Sema4
Patents, Royalties, Other Intellectual Property - I hold patent and royalty with Personalis, Boston University, Stanford University, and Quest Diagnostics.
 
Eric Schadt
Employment - Sema4
Leadership - Sema4
Stock and Other Ownership Interests - Sema4
Consulting or Advisory Role - Berg
Research Funding - GlaxoSmithKline; Janssen; Lilly; Sanofi; Sema4
 
William K. Oh
Consulting or Advisory Role - Advanced Accelerator Applications; Amgen; AstraZeneca; Bayer; Conjupro Biotherapeutics; Foundry; HUYA Bioscience International; Janssen; Sanofi; Sema4; TeneoBio
 
Amy Tiersten
Consulting or Advisory Role - AstraZeneca; Eisai; Immunomedics; Novartis; Puma Biotechnology; Roche/Genentech
Research Funding - AstraZeneca; Genentech/Roche; Lilly; Novartis; pfizer